SCHEMBL16095505

SCHEMBL16095505

O=C(O)c1ccnc(-c2nc(CC3CC3)[nH]c2-c2ccc(Cl)cc2)c1

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 14/20 0.56
▸ KDM5B Q9UGL1 4/20 0.47
▸ KDM5A P29375 3/20 0.47
▸ KDM2B Q8NHM5 3/20 0.43
▸ KMO O15229 1/20 0.43
▸ KDM4A O75164 1/20 0.41
▸ CHEK2 O96017 1/20 0.39
▸ CTRC Q99895 1/20 0.39
▸ CDH1 P12830 1/20 0.38
▸ APC P25054 1/20 0.38
▸ CTNNB1 P35222 1/20 0.38
▸ TCF7L2 Q9NQB0 1/20 0.38
▸ GSK3B P49841 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16094974 0.90 KDM4C (0.56) KDM4CKDM5BKDM5AKDM2BKDM4A
SCHEMBL16095191 0.80 MAPK14 (0.39) KDM4CGSK3BMAPK14
SCHEMBL16095315 0.79 KDM4C (0.60) KDM4CKDM5BKDM5AKDM2BKDM4A
SCHEMBL16094879 0.73 KDM4C (0.61) KDM4CKDM5BKDM5AKMOKDM4A
SCHEMBL16033766 0.72 KDM4C (1.00) KDM4CKDM5BKDM5AKDM2BKDM4A
SCHEMBL31301524 0.72 KMO (0.71) KDM4CKDM5BKDM5AKDM2BKMO
SCHEMBL16095312 0.72 KDM4C (0.60) KDM4CKDM5BKDM5AKDM2BKMO
SCHEMBL16094741 0.70 MAPK14 (0.48) GSK3BMAPK14
SCHEMBL16096065 0.69 KDM4C (0.60) KDM4CKDM5BKDM5AKDM2BKDM4A
SCHEMBL16095834 0.68 KDM4C (0.56) KDM4CKDM5BKDM5AKDM2BKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2969007-A1 HISTONE DEMETHYLASE INHIBITORS Quanticel Pharmaceuticals Inc (US) 2016-01-20 — — EP disclosed
WO-2014151945-A1 HISTONE DEMETHYLASE INHIBITORS Quanticel Pharmaceuticals, Inc. (US) 2014-09-25 — — WO disclosed
Send feedback